Chernogolovka, Russia

Sergey O Bachurin

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 2005-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Sergey O Bachurin: Innovator in Neuropharmacology

Introduction

Sergey O Bachurin is a notable inventor based in Chernogolovka, Russia. He has made significant contributions to the field of neuropharmacology, particularly through his innovative work on tetracyclic compounds. With a total of 3 patents, his research focuses on developing new therapeutic agents for various neurological disorders.

Latest Patents

One of Bachurin's latest patents involves tetracyclic compounds that are designed to modulate histamine receptors in individuals. These compounds, specifically tetracyclic [4,3-b]indoles, have potential applications in treating cognitive disorders, psychotic disorders, and other neuronal issues. Another significant patent details fluoro-containing derivatives of hydrogenated pyrido[4,3-b]indoles, which exhibit neuroprotective and cognition-enhancing properties. These derivatives may be used in the treatment of a wide range of neurological disorders, including Alzheimer's disease, Parkinson's disease, and various forms of dementia. The compounds also serve as pharmacological tools for investigating neurodegeneration mechanisms.

Career Highlights

Throughout his career, Sergey O Bachurin has worked with several prominent companies, including Medivation Technologies, Inc. and D2e, LLC. His work in these organizations has contributed to advancements in neuropharmacological research and development.

Collaborations

Bachurin has collaborated with notable individuals in his field, including Bogdan K Beznosko and Nadezhda Sergeevna Beznosko, who serves as a legal representative. These collaborations have further enhanced his research and patent development.

Conclusion

Sergey O Bachurin's innovative work in neuropharmacology has led to the development of promising therapeutic agents for neurological disorders. His contributions continue to impact the field significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…